Agustin Avilés

Summary

Affiliation: Instituto Mexicano del Seguro Social
Country: Mexico

Publications

  1. doi request reprint Hematological malignancies and pregnancy: treat or no treat during first trimester
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F, Mexico
    Int J Cancer 131:2678-83. 2012
  2. doi request reprint Randomized clinical trial to assess the efficacy of radiotherapy in primary mediastinal large B-lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F, Mexico
    Int J Radiat Oncol Biol Phys 83:1227-31. 2012
  3. doi request reprint The role of genotype in 104 cases of diffuse large B-cell lymphoma primary of breast
    Agustin Avilés
    Hematology Department, Oncology Hospital National Medical Center, IMSS Mexico, Mexico
    Am J Clin Oncol 35:126-9. 2012
  4. ncbi request reprint CMED in the treatment of nasal natural killer cell lymphoma with distant metastases
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Hematology 12:241-4. 2007
  5. ncbi request reprint Antitumor effect of zoledronic acid in previously untreated patients with multiple myeloma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Med Oncol 24:227-30. 2007
  6. ncbi request reprint Dose dense (CEOP-14) vs dose dense and rituximab (CEOP-14 +R) in high-risk diffuse large cell lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Med Oncol 24:85-9. 2007
  7. doi request reprint Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Med Oncol 25:360-4. 2008
  8. doi request reprint Rituximab and chemotherapy in primary gastric lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, Plaza Luis Cabrera 5 502, Colonia Roma, Mexico
    Cancer Biother Radiopharm 24:25-8. 2009
  9. ncbi request reprint Hematological malignancies and pregnancy. A brief review
    Agustin Avilés
    Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Rev Recent Clin Trials 4:131-9. 2009
  10. doi request reprint Rituximab and dose-dense chemotherapy in primary testicular lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, D F Mexico
    Clin Lymphoma Myeloma 9:386-9. 2009

Collaborators

Detail Information

Publications44

  1. doi request reprint Hematological malignancies and pregnancy: treat or no treat during first trimester
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F, Mexico
    Int J Cancer 131:2678-83. 2012
    ..The use of cytotoxic drugs during the first trimester to treat HM seems to be beneficial to both the mother and fetus, and chemotherapy during the first trimester can be considered if the cure of the patient is the goal...
  2. doi request reprint Randomized clinical trial to assess the efficacy of radiotherapy in primary mediastinal large B-lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F, Mexico
    Int J Radiat Oncol Biol Phys 83:1227-31. 2012
    ....
  3. doi request reprint The role of genotype in 104 cases of diffuse large B-cell lymphoma primary of breast
    Agustin Avilés
    Hematology Department, Oncology Hospital National Medical Center, IMSS Mexico, Mexico
    Am J Clin Oncol 35:126-9. 2012
    ..To analyze the role of genotype in patients with diffuse large B-cell lymphoma primary of breast (DLBCL-PB) treated with chemotherapy or immunochemotherapy...
  4. ncbi request reprint CMED in the treatment of nasal natural killer cell lymphoma with distant metastases
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Hematology 12:241-4. 2007
    ..We described a group of patients with these atypical presentation and that were treated with an intensive, short chemotherapy/radiotherapy regimen...
  5. ncbi request reprint Antitumor effect of zoledronic acid in previously untreated patients with multiple myeloma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Med Oncol 24:227-30. 2007
    ..We began a controlled clinical trial with modern treatment (including transplant procedures) in combination with zoledronic acid to define the role of zoledonic acid in this setting of patients...
  6. ncbi request reprint Dose dense (CEOP-14) vs dose dense and rituximab (CEOP-14 +R) in high-risk diffuse large cell lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Med Oncol 24:85-9. 2007
    ..The use of a dense-dose regimen is useful and well tolerated in patients with very high risk diffuse large cell lymphoma. The addition of rituximab did not improve outcome in these setting of patients...
  7. doi request reprint Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Med Oncol 25:360-4. 2008
    ..Acute toxicity was mild and well tolerated. Our results showed that the CMED regimen is feasible and effective in PTCLu...
  8. doi request reprint Rituximab and chemotherapy in primary gastric lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, Plaza Luis Cabrera 5 502, Colonia Roma, Mexico
    Cancer Biother Radiopharm 24:25-8. 2009
    ..We performed a phase II clinical trial to assess the efficacy and toxicity of the addition of rituximab and conventional chemotherapy in primary gastric lymphoma (PGL)...
  9. ncbi request reprint Hematological malignancies and pregnancy. A brief review
    Agustin Avilés
    Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Rev Recent Clin Trials 4:131-9. 2009
    ..It is necessary to consolidate all dates of this association to come to definitive conclusions...
  10. doi request reprint Rituximab and dose-dense chemotherapy in primary testicular lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, D F Mexico
    Clin Lymphoma Myeloma 9:386-9. 2009
    ..Treatment of primary testicular lymphoma (PTL) remains unsatisfactory even in patients with good prognosis, as < 30% of patients are alive at 3 years...
  11. doi request reprint ESHAP versus rituximab-ESHAP in frail patients with refractory diffuse large B-cell lymphoma
    Agustin Avilés
    Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Clin Lymphoma Myeloma Leuk 10:125-8. 2010
    ..Treatment for refractory lymphoma in frail patients (older, poor performance status, or concomitant diseases) has not been defined...
  12. doi request reprint Multiple myeloma and pregnancy
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, 06725 Mexico DF, Mexico
    Am J Hematol 86:81-2. 2011
    ..Longer follow-up (>3 years) did not give evidence of late complications in the children. Three mothers received stem cell transplantation...
  13. ncbi request reprint Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy
    A Aviles
    Oncology Research Unit and Department of Hematology, Oncology Hospital National Medical Center, IMSS, Mexico, D F Mexico
    Ann Oncol 17:286-8. 2006
    ..The outcome of children that received antracyclines during pregnancy, including during the first trimester, remain unknown because long-term follow-up is not available...
  14. ncbi request reprint Addition of a short course of chemotherapy did not improve outcome in patients with localized marginal B-cell lymphoma of the orbit
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, Mexican Institute of Social Security, Mexico, Mexico
    Oncology 70:173-6. 2006
    ..The present study was designed to define if the use of radiotherapy is sufficient in these patients or if the use of adjuvant chemotherapy would improve the outcome...
  15. ncbi request reprint Rituximab and escalated chemotherapy in elderly patients with aggressive diffuse large-cell lymphoma: a controlled clinical trial
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Cancer Biother Radiopharm 22:194-9. 2007
    ..Toxicity was mild and well tolerated. In elderly patients with diffuse large-cell lymphoma and poor prognostic factors, rituximab did not improve their outcome...
  16. ncbi request reprint Primary breast lymphoma: results of a controlled clinical trial
    Agustin Avilés
    Oncology Research Unit, National Medical Center, IMSS, Mexico, Mexico
    Oncology 69:256-60. 2005
    ..To assess the efficacy and toxicity of the most employed therapeutic approaches in the treatment of primary breast lymphoma (PBL)...
  17. ncbi request reprint Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma: malignant lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Med Oncol 21:269-72. 2004
    ..The intensive CEOP-Bleo regimen with increasing doses of cyclophosphamide and epirubicin is a useful and well-tolerated regimen in the treatment of poor prognosis diffuse large B-cell lymphoma...
  18. ncbi request reprint Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome
    Agustin Avilés
    Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Leuk Lymphoma 45:1385-9. 2004
    ..Thus, we felt that adjuvant radiotherapy will be considered as part of the initial treatment in this setting of patients...
  19. ncbi request reprint Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy
    Agustin Avilés
    Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico
    Med Oncol 20:13-7. 2003
    ..The use of intensive more specific chemotherapy and high dose of local radiotherapy, appear to be an excellent therapeutic approach with improvement in EFS and OS...
  20. ncbi request reprint Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Leuk Lymphoma 46:1023-8. 2005
    ..Thus, we would not recommend use of the drug in Hodgkin's disease. ERNA and echocardiogram are early detection tests for cardiac toxicity and can be employed in surveillance studies...
  21. ncbi request reprint Interferon alpha 2b as maintenance therapy improves outcome in follicular lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Leuk Lymphoma 45:2247-51. 2004
    ..The use of aggressive chemotherapy and maintenance therapy with interferon alpha 2b in follicular lymphoma improved outcome; more than 60% of patients remain alive free of disease at longer follow-up...
  22. ncbi request reprint Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma
    Agustin Avilés
    Oncology Research Unit, National Medical Center, IMSS, Mexico, D F Mexico
    Med Oncol 23:295-300. 2006
    ..To assess efficacy and toxicity of the most common therapies--surgery followed by chemotherapy or chemotherapy alone--we began a controlled clinical trial in patients in early stage (I and II 1)...
  23. ncbi request reprint Residual disease after chemotherapy in aggressive malignant lymphoma: the role of radiotherapy
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Med Oncol 22:383-7. 2005
    ..We feel that radiotherapy will be considered as necessary treatment in this special group of patients...
  24. ncbi request reprint Radiotherapy versus combined therapy in early stages with bulky disease aggressive malignant lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Hematology 8:7-10. 2003
    ..We conclude that combined therapy appear to be superior in patients with early stages and bulky disease in patients with aggressive malignant lymphoma...
  25. ncbi request reprint Testicular lymphoma: organ-specific treatment did not improve outcome
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, Mexico
    Oncology 67:211-4. 2004
    ..To assess whether the use of an organ-specific treatment could improve event-free survival (EFS) and overall survival as endpoints in testicular lymphoma in the early stage: IE and IIE...
  26. ncbi request reprint Novel therapy in multiple myeloma
    Agustin Avilés
    Oncology Research Unit, Department of Hematology, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Invest New Drugs 23:411-5. 2005
    ..Controlled clinical trials comparing with conventional chemotherapy will be conducted to define the role of this therapeutic approach...
  27. ncbi request reprint Interferon and low dose methotrexate improve outcome in refractory mycosis fungoides/Sézary syndrome
    Agustin Avilés
    Oncology Research Unit, Nacional Medical Center, IMSS, Mexico, D F Mexico
    Cancer Biother Radiopharm 22:836-40. 2007
    ..Acute toxicity was mild, treatment was well tolerated, and to date no late toxicity has been observed. We conclude that this regimen is a benefit to this setting of patients, with excellent outcome and mild toxicity...
  28. pmc The role of surgery in primary gastric lymphoma: results of a controlled clinical trial
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico
    Ann Surg 240:44-50. 2004
    ....
  29. ncbi request reprint Treatment of advanced Hodgkin's disease: EBVD versus intensive brief chemotherapy
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F, Mexico
    Leuk Lymphoma 44:1361-5. 2003
    ..In the present single center trial, intensive chemotherapy did not appear to have better results when compared with standard chemotherapy in patients with advanced Hodgkin's disease...
  30. ncbi request reprint Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Med Oncol 19:55-8. 2002
    ..Cardiac function was normal before and 12 mo after chemotherapy. Pegylated liposomal doxorubicin appear as an promising drug in the treatment of patients with aggressive malignant lymphoma...
  31. ncbi request reprint Large bowel lymphoma: an analysis of prognostic factors and therapy in 53 patients
    Agustin Avilés
    Department of Hematology, Oncology Hospital, National Medical Center, I M S S, Mexico D F, Mexico
    J Surg Oncol 80:111-5. 2002
    ....
  32. ncbi request reprint Gemcitabine and cisplatin in refractory malignant lymphoma
    Agustin Avilés
    Oncology Research Unit, Mexican Social Security Institute, Mexico City, Mexico
    Oncology 66:197-200. 2004
    ..We performed a pilot study to evaluate the effect of the high-dose gemcitabine-cisplatin combination in a brief weekly regimen in the treatment of primary refractory diffuse large cell lymphoma with high or high-intermediate clinical risk...
  33. ncbi request reprint Combined therapy in advanced stages (III and IV) of follicular lymphoma increases the possibility of cure: results of a large controlled clinical trial
    Agustin Avilés
    Research Unit in Oncological Diseases, Oncology Hospital, National Medical Center, IMSS, Mexico D F, Mexico
    Eur J Haematol 68:144-9. 2002
    ....
  34. ncbi request reprint Maintenance therapy with interferon-alpha 2b, cyclophosphamide, and prednisone in aggressive diffuse large cell lymphoma
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico, D F Mexico
    Stem Cells Dev 13:205-9. 2004
    ..We conclude that use of maintenance therapy combining interferon-alpha 2b, cyclophosphamide, and prednisone is not useful in patients with aggressive lymphoma if they had been treated with aggressive combined chemotherapy...
  35. ncbi request reprint Lack of prognostic factors in follicular lymphoma
    Agustin Avilés
    Oncology Research Unit, The Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Leuk Lymphoma 44:143-7. 2003
    ....
  36. ncbi request reprint In vitro proliferation and expansion of hematopoietic progenitors from patients with diffuse large B-cell lymphoma before and after chemotherapy
    Guadalupe Martínez-Jaramillo
    Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico City, Mexico
    Leuk Lymphoma 45:1247-54. 2004
    ....
  37. doi request reprint Diffuse large B-cell lymphoma primary of lung
    Natividad Neri
    Department of Hematology, Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Hematology 16:110-2. 2011
    ..Treatment was well tolerated, and second late events have not been seen. We conclude that PLL-DLBCL is an extranodal lymphoma with a good prognosis event in patients of non-GC phenotype...
  38. ncbi request reprint Spinal cord compression as a primary manifestation of aggressive malignant lymphomas: long-term analysis of treatments with radiotherapy, chemotherapy or combined therapy
    Agustin Avilés
    Research Unit in Oncological Diseases, Oncology Hospital, National Medical Center, IMSS, Mexico, DF, Mexico
    Leuk Lymphoma 43:355-9. 2002
    ..The use of combined therapy improves the outcome in this group of patients, and so it should be considered the treatment of choice...
  39. ncbi request reprint Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial
    Agustin Avilés
    Oncology Research Unit, National Medical Center, IMSS, Mexico
    Med Oncol 22:57-62. 2005
    ..Thus considered, chemotherapy alone is an effective and safe therapeutic approach in this setting of patients. Surgery or radiotherapy will be reserved to patients that are not candidates for chemotherapy...
  40. ncbi request reprint No association between lymphoma and hepatitis C virus
    Agustin Avilés
    Oncology Research Unit, Oncology Hospital, IMSS, 06700 Mexico, D F Mexico
    Med Oncol 20:165-8. 2003
    ....
  41. doi request reprint Combined therapy in untreated patients improves outcome in nasal NK/T lymphoma: results of a clinical trial
    Agustin Avilés
    Oncology Research Unit, National Medical Center, Oncology Hospital, IMSS, Avenida Cuauthemoc 330, Colonia Doctores, 06700 Mexico, DF, Mexico
    Med Oncol 30:637. 2013
    ..To our knowledge, this is the first controlled clinical trial, with a large number of patients and longer follow-up. Thus, we conclude that CT is the best therapeutic option in this setting of patients. ..
  42. doi request reprint Rituximab in the treatment of diffuse large B-cell lymphoma primary of the lung
    Agustin Avilés
    Oncology Hospital National Medical Center, IMSS, Mexico DF, Mexico
    Hematology 18:81-4. 2013
    ..The results were not statistically different when compared retrospectively with patients who received CHOP alone. Treatment was well tolerated. The addition of rituximab to chemotherapy did not improve outcome in patients with DLBCL-PL...
  43. doi request reprint Central nervous system prophylaxis in patients with aggressive diffuse large B cell lymphoma: an analysis of 3,258 patients in a single center
    Agustin Avilés
    Oncology Research Oncology Diseases, Ave Cuauhtemoc 330, Colonia Doctores, 06725 Mexico, DF, Mexico
    Med Oncol 30:520. 2013
    ..It is evident that multicentric studies are necessary to define the role of prophylaxis in order to prevent CNS relapse and that the therapeutic procedure will be carefully revised...
  44. ncbi request reprint Expression of ice, bcl-2, c-myc and p53 in different bone marrow cell populations from patients with diffuse large B-cell lymphoma
    Mónica Madrigal-Velázquez
    Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico City, Mexico
    Leuk Lymphoma 47:665-73. 2006
    ..To date, the physiological implications of these alterations are still unclear, and further studies should be undertaken to address this issue...